Literature DB >> 30199567

Influence of Microstructure on Stiffening Effects of Corneal Cross-linking Treatment.

Hamed Hatami-Marbini.   

Abstract

PURPOSE: To investigate the stiffening effects of corneal cross-linking (CXL) on tensile properties of anterior and posterior corneal flaps.
METHODS: A Descemet stripping automated endothelial keratoplasty system was used to prepare anterior and posterior flaps from porcine corneas. The flaps were subjected to CXL and their mechanical behavior was assessed by conducting uniaxial tensile experiments. Full-thickness corneas were also cross-linked from the posterior and anterior side and their tensile behavior was measured.
RESULTS: The CXL procedure significantly improved biomechanical properties of anterior flaps (P < .05). CXL did not have any significant effect on tensile properties of posterior flaps. Cross-linking full-thickness porcine corneal stroma from the posterior side had no significant stiffening effect.
CONCLUSIONS: The stiffening effect of CXL therapy depends significantly on the composition and microstructure of corneal extracellular matrix. [J Refract Surg. 2018;34(9):622-627.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30199567     DOI: 10.3928/1081597X-20180718-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Depth-Dependent Reduction of Biomechanical Efficacy of Contact Lens-Assisted Corneal Cross-linking Analyzed by Brillouin Microscopy.

Authors:  Hongyuan Zhang; Mehdi Roozbahani; Andre L Piccinini; Oren Golan; Farhad Hafezi; Giuliano Scarcelli; J Bradley Randleman
Journal:  J Refract Surg       Date:  2019-11-01       Impact factor: 3.573

2.  Brillouin microscopic depth-dependent analysis of corneal crosslinking performed over or under the LASIK flap.

Authors:  Hongyuan Zhang; Mehdi Roozbahani; Andre L Piccinini; Farhad Hafezi; Giuliano Scarcelli; J Bradley Randleman
Journal:  J Cataract Refract Surg       Date:  2020-11       Impact factor: 3.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.